Lv1
75 积分 2020-11-01 加入
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
22小时前
待确认
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer
3个月前
已完结
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer
3个月前
已完结
Reciprocal regulation of T follicular helper cells and dendritic cells drives colitis development
3个月前
已完结
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study
3个月前
已关闭
Long-term survivorship after chimeric antigen receptor T-cell therapy for hematologic malignancies. Journal of Clinical Oncology, 44(8), 698–708
5个月前
已关闭
The Golgi complex in disease and therapy
5个月前
已完结
Potential therapies and diagnosis based on Golgi-targeted nano drug delivery systems
5个月前
已完结
The Golgi apparatus as a strategic target in cancer: mechanisms, diagnosis and therapeutic opportunities
5个月前
已完结
Hamilton MP, Miklos DB, Alizadeh AA. Risk of second tumors and T-cell lymphoma after CAR T-cell therapy. N Engl J Med 2024; 391: 870–71
5个月前
已完结
皖公网安备34019202002308
